We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00228098
Recruitment Status : Unknown
Verified September 2005 by Odense University Hospital.
Recruitment status was:  Recruiting
First Posted : September 28, 2005
Last Update Posted : September 28, 2005
Sponsor:
Collaborators:
Information provided by:

Study Description
Brief Summary:

Patients with stroke or transient ischemic attach should receive advise on smoking cessation. It is however unknown if an intensive smoking cessation program is better than ordinary advise on smoking cessation during hospitalisation for stroke or transient ischemic attack.

The aim of the study was to assess if an intensive smoking cessation program made more patients stop smoking after stroke or transient ischemic attack.


Condition or disease Intervention/treatment
Stroke Transient Ischemic Attack Behavioral: Smoking cessation

Detailed Description:

Patients with stroke or transient ischemic attach should receive advise on smoking cessation. It is however unknown if an intensive smoking cessation program is better than ordinary advise on smoking cessation during hospitalisation for stroke or transient ischemic attack.

The aim of the study was to assess if an intensive smoking cessation program made more patients stop smoking after stroke or transient ischemic attack.

Patients with stroke or transient ischemic attack are admitted to the department of neurology at Odense University hospital. Patient who are smokers on admission and age < 76 years, inhabitants in Funen County and with symptoms developed before admission will be offered participation in the study unless they have severe stroke, stroke more than 3 weeks before admission, other severe disease or unable to participate.

Study participants will be randomised to either usual short advise on smoking cessation or an intensive smoking cessation program. All participants will be followed-up for 6 months with regard to smoking habits.


Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 300 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack. A Randomised Controlled Trial
Study Start Date : February 2005
Estimated Study Completion Date : February 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions


Outcome Measures

Primary Outcome Measures :
  1. Smoking cessation rate

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age < 76 years
  • Inhabitant in Funen County
  • Acute stroke or transient ischemic attack
  • Symptoms with onset before admission
  • Current smoker on admission

Exclusion Criteria:

  • Severe stroke
  • Current stroke onset more than 3 weeks before admission
  • Other severe disease
  • Unable to participate
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00228098


Locations
Denmark
Department of Neurology Recruiting
Odense, Funen, Denmark, 5000 C
Contact: Søren Bak, MD, PhD.       bak@hunderupnet.dk   
Sponsors and Collaborators
Odense University Hospital
Danish Heart Foundation
Hjernesagen
Funen County
Investigators
Principal Investigator: Søren Bak, MD, PhD Department of Neurology, Odense University Hospital. 5000 Odense C. Denmark
More Information

ClinicalTrials.gov Identifier: NCT00228098     History of Changes
Other Study ID Numbers: VF 20040136
First Posted: September 28, 2005    Key Record Dates
Last Update Posted: September 28, 2005
Last Verified: September 2005

Additional relevant MeSH terms:
Stroke
Ischemia
Ischemic Attack, Transient
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Pathologic Processes
Brain Ischemia